NVO - 3 Top Diabetes Stocks to Buy in August
Diabetes is a huge concern in the United States. According to the Centers for Disease Control and Prevention (CDC), more than 34 million people in the United States have diabetes, and 20% of them don't know they have it. That doesn't count the 88 million people in the United States who the CDC says are in the prediabetic stage.
The CDC said the number of people living with diabetes has more than doubled over the past 20 years, so the market presents a huge opportunity for companies that concern themselves with treating the disease. The most common form of diabetes is type 2, which CDC research says occurs in 90%-95% of diabetes patients.
If you're looking to invest in companies treating diabetes, DexCom (NASDAQ: DXCM), Tandem Diabetes Care (NASDAQ: TNDM), and Novo Nordisk (NYSE: NVO) are worth looking at this month in the healthcare space.